Catalyst Capital Advisors LLC Dexcom Inc Transaction History

Catalyst Capital Advisors LLC

$4.89 Billion
Q3 2025

A detailed history of Catalyst Capital Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 197 shares of DXCM stock, worth $11,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares

197

Previous 241 18.26%

Holding current value

$11,437

Previous $21,000 38.1%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$66.46 - $89.53 $2,924 - $3,939	-44 Reduced 18.26%	197 $13,000
Q2 2025 Jul 31, 2025	SELL	$59.83 - $87.57 $3,769 - $5,516	-63 Reduced 20.72%	241 $21,000
Q1 2025 Apr 29, 2025	SELL	$67.74 - $90.75 $49,382 - $66,156	-729 Reduced 70.57%	304 $20,000
Q4 2024 Jan 31, 2025	BUY	$65.68 - $81.01 $47,683 - $58,813	726 Added 236.48%	1,033 $80,000
Q3 2024 Oct 30, 2024	SELL	$64.0 - $116.06 $4,992 - $9,052	-78 Reduced 20.26%	307 $20,000

Q2 2024 Jul 25, 2024	BUY	$110.31 - $140.45 $1,654 - $2,106	15 Added 4.05%	385 $43,000
Q1 2024 Apr 24, 2024	BUY	$114.22 - $140.1 $685 - $840	6 Added 1.65%	370 $51,000
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $5,812 - $9,560	77 Added 26.83%	364 $45,000
Q3 2023 Nov 09, 2023	BUY	$86.06 - $137.93 $6,368 - $10,206	74 Added 34.74%	287 $26,000
Q2 2023 Aug 08, 2023	SELL	$112.47 - $130.98 $2,024 - $2,357	-18 Reduced 7.79%	213 $27,000
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $7,384 - $8,727	-71 Reduced 23.51%	231 $26,000
Q4 2022 Feb 07, 2023	SELL	$84.98 - $122.67 $934 - $1,349	-11 Reduced 3.51%	302 $34,000
Q3 2022 Nov 08, 2022	BUY	$76.35 - $94.18 $76 - $94	1 Added 0.32%	313 $25,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $16,657 - $32,558	245 Added 365.67%	312 $23,000
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $1,223 - $1,692	13 Added 24.07%	67 $34,000
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $519 - $651	-4 Reduced 6.9%	54 $29,000
Q3 2021 Nov 09, 2021	SELL	$106.71 - $143.18 $106 - $143	-1 Reduced 1.69%	58 $32,000
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $161 - $215	2 Added 3.51%	59 $25,000
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $932 - $1,152	-11 Reduced 16.18%	57 $20,000
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $1.48 Million - $1.98 Million	-18,932 Reduced 99.64%	68 $25,000
Q3 2020 Nov 05, 2020	SELL	$95.51 - $112.95 $114,612 - $135,540	-1,200 Reduced 5.94%	19,000 $7.83 Million
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $294,596 - $495,098	4,700 Added 30.32%	20,200 $8.19 Million
Q1 2020 May 12, 2020	BUY	$47.79 - $75.63 $740,745 - $1.17 Million	15,500 New	15,500 $4.17 Million

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

376M

Call Options Held

6.76M

Put Options Held

7.24M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Account

Catalyst Capital Advisors LLC Dexcom Inc Transaction History